Cellusion participated the mini seminar in ISSCR & JSRM 2021 Tokyo International Symposium “Stem Cells: From Basic Science to Clinical Translation”

Dr. Hatou presented Cellusion business progress in the 2021 Cell & Gene Meeting on the Mesa.

Cellusion obtained 1st prize of Boehringer Ingelheim Innovation Prize 2021

Cellusion welcomes Stella and Toru as new board members

CLS001 Non-clinical Efficacy Study Result was published in Stem Cell Research.

CLS001 Clinical Study Plan Officially Approved by MHLW‘s Health Science Council

The Clinical Study Plan on Corneal Endothelial Cell Substitute from iPS Cells Transplant Plan for Bullous Keratopathy Patient approved by MHLW‘s Health Science Council

Dr. Hatou presents recent research progress in 2021 ISSCR VIRTUAL conference.

Keio Univ.’s Corneal Endothelial Cell Substitute from iPS Cells Transplant Plan on Bullous Keratopathy Treatment OK’d

Cellusion introduced in The Nikkan Kogyo Shimbun.